Inventor
SCHWAB WILFRIED
DE50 patents
⚠️ This page may combine multiple inventors who share the name “SCHWAB WILFRIED”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOECHST AG
13 patentsUS5314863AMay 24, 1994
Isoxazolines, their preparation, and their use as plant-protecting agents
HOECHST AG92 citations94
US5814627ASep 29, 1998
3, 5-disubstituted and 3, 4, 5-trisubstituted 2-isoxazolines and isoxazoles, process for their preparation and their use as pharmaceuticals
HOECHST AG40 citations92
US4667028AMay 19, 1987
Process for the preparation of cephem compounds
HOECHST AG39 citations92
US4647556AMar 3, 1987
Cephalosporin derivatives
HOECHST AG43 citations92
US5273989ADec 28, 1993
3,5-disubstituted 2-isoxazolines and isoxazoles, agents containing them and their use
HOECHST AG29 citations87
US6121479ASep 19, 2000
Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics
HOECHST AG7 citations73
US5977151ANov 2, 1999
Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics
HOECHST AG9 citations73
US5006515AApr 9, 1991
Pharmaceuticals, phosphorus-containing 2-isoxazolines and isoxazoles contained therein
HOECHST AG7 citations72
US5886033AMar 23, 1999
Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders
HOECHST AG11 citations71
US4692516ASep 8, 1987
Process for the manufacture of 3-pyridinium-methyl-cephalosporins
HOECHST AG7 citations62
US6121316ASep 19, 2000
2-cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives
HOECHST AG2 citations60
US6020372AFeb 1, 2000
Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders
HOECHST AG4 citations60
US4770861ASep 13, 1988
Recovery of cesium chloride from contaminated solutions
HOECHST AG0 citations51
AVENTIS PHARMA GMBH
12 patentsUS6159995ADec 12, 2000
Substituted diaminocarboxylic acids
AVENTIS PHARMA GMBH72 citations95
US6451824B1Sep 17, 2002
Sulfonylaminocarboxylic acids
AVENTIS PHARMA GMBH37 citations92
US6265588B1Jul 24, 2001
Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics
AVENTIS PHARMA GMBH34 citations92
US6207672B1Mar 27, 2001
Cyclic and heterocyclic N-substituted α-iminohydroxamic and carboxyclic acids
AVENTIS PHARMA GMBH25 citations92
US6815440B2Nov 9, 2004
Cyclic and heterocyclic N-substituted α-iminohydroxamic and -carboxylic acids
AVENTIS PHARMA GMBH12 citations73
US6335333B1Jan 1, 2002
N-arylsulfonylamino acid omega-amides
AVENTIS PHARMA GMBH11 citations73
US6355673B1Mar 12, 2002
Substituted diaminocarboxylic acids
AVENTIS PHARMA GMBH5 citations62
US6235727B1May 22, 2001
Sulfonylaminophosphinic and sulfonylaminophosphinic acid derivatives, methods for their preparation and use
AVENTIS PHARMA GMBH4 citations62
US6894184B2May 17, 2005
Process for preparing 2-cyano-3-hydroxy-N-(phenyl)but-2-enamides
AVENTIS PHARMA GMBH6 citations56
US6500811B2Dec 31, 2002
Sulfonylaminophosphinic and sulfonylaminophosphonic acid derivatives, methods for their preparation and use
AVENTIS PHARMA GMBH0 citations52
US6387934B1May 14, 2002
2-Cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives
AVENTIS PHARMA GMBH0 citations50
US6172103B1Jan 9, 2001
2-cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives
AVENTIS PHARMA GMBH0 citations50
AICURIS ANTI INFECTIVE CURES GMBH
7 patentsUS10137117B2Nov 27, 2018
Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations
AICURIS ANTI INFECTIVE CURES GMBH6 citations81
US9889124B2Feb 13, 2018
Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations
AICURIS ANTI INFECTIVE CURES GMBH6 citations81
US11266636B2Mar 8, 2022
Maleate salt of the free base of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide, pharmaceutical formulations, methods of manufacture and uses thereof for the treatment of herpes viruses
AICURIS ANTI INFECTIVE CURES GMBH2 citations68
US11021474B2Jun 1, 2021
N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof
AICURIS ANTI INFECTIVE CURES GMBH4 citations68
USRE49697EOct 17, 2023
Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations
AICURIS ANTI INFECTIVE CURES GMBH0 citations60
US12152022B2Nov 26, 2024
N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof
AICURIS ANTI INFECTIVE CURES GMBH0 citations58
US10442773B2Oct 15, 2019
Amorphous letermovir and solid pharmaceutical formulations thereof for oral administration
AICURIS ANTI INFECTIVE CURES GMBH1 citations55
AICURIS GMBH & CO KG
5 patentsUS9119786B2Sep 1, 2015
Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations
AICURIS GMBH & CO KG15 citations90
US9637459B2May 2, 2017
Sodium and calcium salts of dihydroquinazoline derivative and use thereof as antiviral agents
AICURIS GMBH & CO KG4 citations71
US9340535B2May 17, 2016
N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate
AICURIS GMBH & CO KG5 citations71
US12070451B2Aug 27, 2024
Sulfate salt of the free base of n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide, pharmaceutical formulations, methods of manufacture and uses thereof
AICURIS GMBH & CO KG1 citations57
US10603384B2Mar 31, 2020
Pharmaceutical composition containing an antivirally active dihydroquinazoline derivative
AICURIS GMBH & CO KG0 citations36